News

Arsenal’s Value Demonstration Business Acquires Guidemark Health

Acquisition further enhances capabilities in medical affairs and commercial to support life sciences clients in optimizing the value of their products and accelerating patient access to medical and technological advances Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in building healthcare businesses, announced today the acquisition of Guidemark Health (“Guidemark”), a leading healthcare marketing communications, training, and medical education agency. Guidemark is the third acquisition for Arsenal’s Value Demonstration organization, following the acquisitions of Read more…

By Guidemark Health, ago

A Call to Action During Breast Cancer Awareness Month

One year and six months after the FDA heard from dozens of women reporting a variety of breast implant related ailments, the federal agency has issued guidelines for breast implant manufacturers to include a black box warning  (https://bit.ly/3kz9Hnm) to implants filled with saline or silicone gel. As we reflect on this important news during Breast Cancer Awareness Month 2020, we must celebrate the impact of the wider movement over the years. No one can argue Read more…

By Jackie Singley, ago

Focusing on Professional Growth in 2020

By: Melissa Tarantino, Guidemark Health, Speaker Bureau Lead Here is a question not being asked very often despite the current COVID-19 environment. How do we continue to grow professionally in 2020? I am sure I am not alone when I say that 2020 was off to a strong start. We all started the year, as we typically do, thinking about or writing down specific personal and professional goals that we wanted to accomplish in 2020 Read more…

By Melissa Tarantino, ago

Finding Understanding in a World of Isolation and Containment

We entered March with great energy and excitement for the upcoming activities that have forever defined this season: spring training baseball, national sales meetings, new product launch meetings, and of course full-contact action from medical congress meetings like AACR and ASCO. Enter COVID-19 and as we quickly shifted to a virtually connected, eventless world, we found ourselves quickly pivoting to embrace new ways of conducting business and new ways of staying engaged with family and loved Read more…

By Michael Parisi, ago

Part III: Bringing a Winning Idea to Market

Happy new year colleagues and friends! It is hard to believe this month marks the one year anniversary of our inaugural Health Action Community event, focused on addressing unmet needs in metastatic breast cancer (MBC). As I reflect on the progress made since last January, I thought now is an ideal time to share details from the day, acknowledge the many contributions of the participants, and provide an update on action steps since the event. Read more…

By Jackie Singley, ago
Logo: Lung Cancer Awareness, Keep the Dialogue Going

Do liquid biopsies represent a foregone conclusion in first line of testing?

“Gold standard” and “minimally invasive” get ingrained in physicians’ heads early on in medical school, and later become the foundational pillars for patient care. When determining the best cancer treatment, “gold standard” means taking a tissue biopsy from the patient to genetically profile a tumor. Unfortunately, for many patients, this requires a procedure that is usually invasive, oftentimes painful, and may not yield enough tissue to sample. Enter the liquid biopsy. A liquid biopsy is Read more…

By Payal Trivedi, MD, ago
Logo: Lung Cancer Awareness, Keep the Dialogue Going

A Month of Awareness and Thanks

November is more than just the Season of Giving—it’s also Lung Cancer Awareness Month. Last week, my wife and I attended LUNGevity’s 7th annual Celebration of Hope Gala in NYC where I had the privilege of meeting many of the people in this picture. It’s truly inspiring to say that everyone in the picture below is a lung cancer survivor! What absolutely blew my mind was the number of survivors in the room…. think about Read more…

By Michael Parisi, ago